Patents by Inventor Bradley C. Peck

Bradley C. Peck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10289280
    Abstract: A device for programming an implantable fluid delivery device receives a therapeutic agent concentration, wherein the therapeutic agent concentration comprises a mass of the therapeutic agent per unit of volume. The device further determines a reference rate value based on the received therapeutic agent concentration, wherein the reference rate value comprises a mass per unit of time. The device additionally displays a graphical user interface comprising a horizontal axis and a vertical axis, wherein the horizontal axis represents time and the vertical axis represents rates of delivery of the fluid by the implantable fluid delivery device. The maximum value of the vertical axis displayed in the graphical user interface is determined based on the determined reference rate value and is determined to be less than a maximum therapeutic agent infusion rate.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: May 14, 2019
    Assignee: Medtronic, Inc.
    Inventors: Ajinkya M. Joglekar, Bradley C. Peck
  • Publication number: 20140365941
    Abstract: A device for programming an implantable fluid delivery device receives a therapeutic agent concentration, wherein the therapeutic agent concentration comprises a mass of the therapeutic agent per unit of volume. The device further determines a reference rate value based on the received therapeutic agent concentration, wherein the reference rate value comprises a mass per unit of time. The device additionally displays a graphical user interface comprising a horizontal axis and a vertical axis, wherein the horizontal axis represents time and the vertical axis represents rates of delivery of the fluid by the implantable fluid delivery device. The maximum value of the vertical axis displayed in the graphical user interface is determined based on the determined reference rate value and is determined to be less than a maximum therapeutic agent infusion rate.
    Type: Application
    Filed: June 7, 2013
    Publication date: December 11, 2014
    Inventors: Ajinkya M. Joglekar, Bradley C. Peck
  • Patent number: 8463382
    Abstract: A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: June 11, 2013
    Assignee: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Publication number: 20100324629
    Abstract: A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.
    Type: Application
    Filed: August 26, 2010
    Publication date: December 23, 2010
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahistrand, Bradley C. Peck
  • Patent number: 7797047
    Abstract: An implantable medical device (IMD) includes a lead status monitoring system. The lead status monitoring system employs a method including the steps of: collecting data sets from a lead impedance source, a stimulation threshold source, and at least one additional source included in the IMD; and processing the data sets to determine if a lead status event has occurred.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: September 14, 2010
    Assignee: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Patent number: 7738959
    Abstract: Undersensing of an evoked response during an automatically initiated search of the stimulation threshold in a stimulation channel of an IMD, e.g., the pacing threshold in a pacing channel of a pacing system, is minimized by repeating the search using the sense amplifier of the stimulation channel configured in bipolar and unipolar sensing configurations. A failure to sense an evoked response in the search in one sensing configuration can be confirmed, and stimulation energy set to a high output, if an evoked response is not sensed in an alternate sensing configuration or refuted if an evoked response is sensed in the alternate sensing configuration. If the failure is refuted, the alternate sensing configuration is employed until the next search.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: June 15, 2010
    Assignee: Medtronic, Inc.
    Inventors: Christopher M. Manrodt, Todd J. Sheldon, Bradley C. Peck
  • Publication number: 20040162593
    Abstract: A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.
    Type: Application
    Filed: February 18, 2004
    Publication date: August 19, 2004
    Applicant: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Patent number: 6721600
    Abstract: A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: April 13, 2004
    Assignee: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Publication number: 20040064162
    Abstract: Undersensing of an evoked response during an automatically initiated search of the stimulation threshold in a stimulation channel of an IMD, e.g., the pacing threshold in a pacing channel of a pacing system, is minimized by repeating the search using the sense amplifier of the stimulation channel configured in bipolar and unipolar sensing configurations. A failure to sense an evoked response in the search in one sensing configuration can be confirmed, and stimulation energy set to a high output, if an evoked response is not sensed in an alternate sensing configuration or refuted if an evoked response is sensed in the alternate sensing configuration. If the failure is refuted, the alternate sensing configuration is employed until the next search.
    Type: Application
    Filed: September 30, 2002
    Publication date: April 1, 2004
    Inventors: Christopher M. Manrodt, Todd J. Sheldon, Bradley C. Peck
  • Patent number: 6445952
    Abstract: An apparatus and method for detecting micro-dislodgment at a heart tissue/pacing lead electrode interface involves measuring a first pacing threshold parameter at a first time in a patient's cardiac cycle and measuring a second pacing threshold parameter at a second time in the patient's cardiac cycle. Micro-dislodgment occurring at the heart tissue/pacing lead electrode interface is detected using the first and second pacing threshold parameters. Micro-dislodgment may be detected by comparing a difference between, or a ratio of, the first and second pacing threshold parameters to a preestablished maximum allowable deviation value. A difference between the first and second pacing threshold parameters or a ratio in excess of the preestablished maximum allowable deviation value indicates a problem at the heart tissue/pacing lead interface.
    Type: Grant
    Filed: May 18, 2000
    Date of Patent: September 3, 2002
    Assignee: Medtronic, Inc.
    Inventors: Christopher M. Manrodt, H. Toby Markowitz, Bradley C. Peck
  • Publication number: 20020120307
    Abstract: A system for monitoring trends in lead impedance includes collecting data from various sources in an implantable medical device system. Lead impedance, non-physiologic sensed events percentage of time in mode switch, results of capture management operation, sensed events, adversion pace counts, refractory sense counts and similar data are used to determine the status of a lead. A set of weighted sum rules are implemented by a software system to process the data and provide displayable information to health care professionals via a programmer. The lead monitoring system includes a patient alert system for patients to seek help in the event a serious lead condition is identified.
    Type: Application
    Filed: December 31, 2001
    Publication date: August 29, 2002
    Applicant: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Patent number: 6317633
    Abstract: An implantable medical device (IMD) coupled with leads extending to body tissue providing storage of lead related data, monitoring of lead functional status, and indication of lead integrity to the clinician. A lead status monitor (LSM) processes lead related data in a system self test mode and provides a lead status report that identifies and declares conductor/connector issues, insulation issues, and electrode/tissue interface issues indicative of suspected lead related condition mechanisms for each lead employed in the IMD. The LSM operates employing a set of LSM rules that process measured lead impedance values and loss of capture (LOC) values. In a pacing system, particular LSM rules are defined that process periodically determined, pacing pulse characteristic at LOC and bipolar and unipolar lead impedance values that are measured periodically. The lead impedance values are compared to upper and lower limits or trip points of a normal impedance range.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: November 13, 2001
    Assignee: Medtronic, Inc.
    Inventors: David J. Jorgenson, Ross O. Starkson, Rick D. McVenes, Charles D. Trautmann, John D. Wahlstrand, Bradley C. Peck
  • Patent number: 6163724
    Abstract: A software programmable device means such as a microprocessor discriminates between evoked response signals and post-pace polarization signals sensed by an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window . The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: August 27, 1999
    Date of Patent: December 19, 2000
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Robert John Schuelke
  • Patent number: 6144881
    Abstract: A method and apparatus for discriminating between evoked response signals and post-pace polarization signals sensed by a sense amplifier of an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. The post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window. The sign of the post-pace polarization polarity, either positive or negative, is determined. The evoked response signal may reverse the polarity of the sensed signal from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: November 7, 2000
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Robert John Schuelke
  • Patent number: 6134473
    Abstract: A software programmable microprocessor discriminates between evoked response signals and post-pace polarization signals sensed by an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window. The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: October 17, 2000
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Robert John Schuelke
  • Patent number: 5954756
    Abstract: The present invention employs software programmable device means such as a microprocessor to discriminate between evoked response signals and post-pace polarization signals sensed by an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window. The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: September 21, 1999
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison
  • Patent number: 5873898
    Abstract: The programmable device means such as a microprocessor are employed to discriminate between evoked response signals and post-pace polarization signals sensed by an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window . The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: February 23, 1999
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Robert John Schuelke
  • Patent number: 5871512
    Abstract: Software programmable device means such as a microprocessor are employed to discriminate between evoked response signals and post-pace polarization signals sensed by an implantable medical device. The polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes is monitored during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window. The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: February 16, 1999
    Assignee: Medtronic, Inc.
    Inventors: Michael Todd Hemming, Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Robert John Schuelke
  • Patent number: 5861013
    Abstract: The present invention permits discrimination between evoked response signals and post-pace polarization signals sensed by an implantable medical device by noting the polarity of the positive or negative change in voltage in respect of time (or dv/dt) of the waveform incident on the lead electrodes during a short period of time immediately following a paced event. It has been discovered that the post-pace polarization signal exhibits a relatively constant polarity during the capture detect window, and that the evoked response signal may cause the polarity of post-pace polarization signal to reverse during the capture detect window. The sign of the post-pace polarization polarity, either positive or negative, is determined by the design of the specific output circuitry. The evoked response signal may reverse the polarity of the sensed signal in either case, from positive to negative or from negative to positive, during the time window of interest.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: January 19, 1999
    Assignee: Medtronic Inc.
    Inventors: Bradley C. Peck, Brian A. Blow, Scott M. Morrison, Michael Todd Hemming, Robert John Schuelke